Wisconsin Administrative Code › Department of Children and Families › DCF 101-199 - Family and Economic Security › Chapter DCF 154 - Substance Abuse Screening, Testing, And Treatment for The Children First Program › Section DCF 154.02 - Definitions

Current through June 24, 2024
In this chapter:
(1) "Administering agency" has the meaning
				given in s.
				49.162(1)
				(a), Stats.
(2) "Confirmation test" means an analytical
				procedure used to quantify a specific controlled substance or its metabolite in
				a specimen through a test that is different in scientific principle from that
				of the initial test procedure and capable of providing requisite specificity,
				sensitivity, and quantitative accuracy to positively determine use of a
				controlled substance.
(3)
				"Controlled substance" or "substance" has the meaning given for "controlled
				substance" in s.
				961.01(4),
				Stats.
(4) "Department" means the
				department of children and families.
(4m) "Medical review officer" means a
				licensed physician employed by or providing services under contract to a drug
				testing vendor who has knowledge of substance abuse disorders and laboratory
				testing procedures and who has the necessary training and experience to
				interpret and evaluate a person's positive test result in relation to that
				person's medical history and current valid prescriptions.
(5) "Metabolite" means a chemical present in
				the body when a controlled substance is being broken down through natural
				metabolic processes that can be detected or measured as a positive indicator
				that a controlled substance associated with the metabolite has been
				used.
(7) "Person" means a parent
				who is not a custodial parent under s.
				767.55(2)
				(a), Stats., who has been ordered by the
				court pursuant to s.
				767.55(2)
				(am), Stats., to participate in a work
				experience and job training program under s.
				49.36,
				Stats.
(8) "Reasonable suspicion"
				means suspicion of controlled substance abuse by a person based on that
				person's score on a screening questionnaire.
(9) "Screening" means completion of a
				questionnaire regarding the person's current and prior use of controlled
				substances.
(10) "Specimen" means
				tissue, fluid, or a product of the human body capable of revealing the presence
				of controlled substances or their metabolites.
(11) "Treatment" means services that are
				conducted under clinical supervision to assist a person through the process of
				recovery from controlled substance abuse and may include screening for abuse of
				controlled substances, application of approved placement criteria, intake,
				orientation, assessment, individualized treatment planning, intervention,
				individual or group and family counseling, referral, discharge planning, after
				care or continuing care, recordkeeping, consultation with other professionals
				regarding the patient's treatment, recovery and case management, crisis
				intervention, client education, employment, and problem resolution in life
				skills functioning.
(12) "Treatment
				program" means a program certified to provide treatment for controlled
				substance abuse as a medically managed inpatient service under s.
				DHS
				75.10, a medically monitored treatment service under
				s.
				DHS
				75.11, a day treatment service under s.
				DHS 75.12,
				an outpatient treatment service under s.
				DHS
				75.13, a transitional residential treatment service
				under s.
				DHS
				75.14, or a narcotic treatment service for opiate
				addiction under s.
				DHS
				75.15.
(13) "Treatment provider" or "provider" means
				a provider of treatment for controlled substance abuse certified by the
				department of health services under the provisions of ch. DHS 75.
(14) "Work experience program" or "program"
				means a work experience program for noncustodial parents under s.
				49.36,
				Stats.